<?xml version="1.0" encoding="UTF-8"?>
<p>Based on the best available data, the use of noninvasive positive pressure ventilation as an initial strategy for the treatment of COVID-19â€“associated ARDS is likely reasonable in the subset of patients with mild ARDS, those in whom COPD exacerbation or heart failure may also be contributing to respiratory distress, and when the patient is closely monitored for improvement or worsening respiratory distress.
 <sup>
  <xref rid="R49" ref-type="bibr">49</xref>,
  <xref rid="R50" ref-type="bibr">50</xref>
 </sup>
</p>
